Eruptive Nevus Following Rituximab Treatment: Unusual Dermoscopic Presentation: A Case Report
Journal Title: Journal of Dermatology Research - Year 2024, Vol 5, Issue 1
Abstract
Background: Eruptive nevi can occur following various conditions, including the use of immunosuppressive and immunomodulatory drugs such as biologics. Dermoscopy typically reveals a pattern of brown globules arranged in a ring at the periphery. We report a case of eruptive nevus with an atypical dermoscopic pattern in a patient receiving Rituximab. Observation: A 37-year-old female patient, followed for acquired bullous epidermolysis, developed pigmented and extensive macules six months later. Dermoscopy of a lesion on the trunk, which was increasing in size, showed a homogeneous brown pattern with irregularly arranged brown globules and dots at the center and periphery. Biopsy revealed a junctional nevus. Conclusion: The atypical brown pattern on dermoscopy of eruptive nevi is described for the first time, particularly after rituximab therapy.
Authors and Affiliations
Ghita Sqalli Houssini1*, Hanane Baybay1, Zakia Douhi1, Meryem Soughi1, Sara Elloudi1, Mounia Rimani², Fatima Zahra Mernissi1
Keywords
Related Articles
- EP ID EP733585
- DOI https://doi.org/10.46889/JDR.2024.5114
- Views 56
- Downloads 0
Diagnosis of HyperIgE Syndromes (HIES) on Black Phenotype Patients with Atopic Dermatitis Followed in Dakar, Senegal
This study aimed to determine the epidemiological and clinical-biological manifestation of hyper IgE syndromes during atopic dermatitis in the pediatric dermatology department of the Centre Hospitalier National d’Enfants...
Androgenetic Alopecia: A Study on The Efficacy of a Combined Protocol of Blue Light Photobiomodulation and Subcutaneous Infiltrations of Biomimetic Peptides
Androgenetic Alopecia (AGA) is a common condition affecting men and women, characterized by progressive hair follicle miniaturization and consequent hair loss. Blue light Photobiomodulation (PBM) by LED (Light emitting d...
Impact of the Affordable Care Act on Insurance Status of Patients Newly Diagnosed With Kaposi Sarcoma
Background: The Affordable Care Act (ACA) role in changing the insurance composition of patients diagnosed with many dermatological conditions, such as Kaposi Sarcoma (KS), has not been assessed. Methods: The Surveill...
The Impact of PRAME Expression on Breslow Depth in Melanoma Arising in Dysplastic Nevi in a Large Multi-State Dermatology Group
Background: PRAME immunohistochemistry has been reported to be positive in at least 83.2% of invasive melanomas while being positive in no more than 13.6% of benign nevi. Melanoma may arise within pre-existing nevi or dy...
JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report
Baricitinib, a JAK1/2 inhibitor, has been expanding its role as a therapeutic agent with recent FDA approval for dermatologic use with alopecia areata. Clinical trials are underway for further use of baricitinib for seve...